Cost-Utility Analysis of Disease-Modifying Drugs in Relapsing-Remitting Multiple Sclerosis in Iran
Nov 1, 2013, 00:00 AM
10.1016/j.jval.2013.08.1833
https://www.valueinhealthjournal.com/article/S1098-3015(13)03738-8/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1671
First Page :
A624
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03738-8&doi=10.1016/j.jval.2013.08.1833